BioCentury
ARTICLE | Clinical News

Procyon preclinical data

February 1, 1999 8:00 AM UTC

PBP published in The Prostate that PSP94 inhibited tumor growth in a mouse model of prostate cancer by up to 60 percent compared to untreated controls. The results suggest that PSP94 inhibits tumor gr...